New Data in HFpEF

CME

ACC 2022: Expert Analysis of New Data in HFpEF

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: April 26, 2022

Expiration: April 25, 2023

Lee R. Goldberg
Lee R. Goldberg, MD, MPH, FACC

Pretest

Progress
1 2
Course Completed
1.

In the post hoc analysis of PARAGON-HF, sacubitril/valsartan treatment was associated with which outcome in persons with heart failure with preserved ejection fraction (HFpEF) with and without diabetes vs valsartan alone?